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ABSTRACT 
 
We studied the effects of epidermal growth factor receptor (EGFR) density on tumor growth 
dynamics, both on the sub- and the multi-cellular level using our previously developed model. 
This algorithm simulates the growth of a brain tumor using a multi-scale two-dimensional 
agent-based approach with an integrated transforming growth factor α (TGFα) induced 
EGFR-gene-protein interaction network. The results confirm that increasing cell receptor 
density correlates with an acceleration of the tumor system’s spatio-temporal expansion 
dynamics. This multicellular behavior cannot be explained solely on the basis of spatial sub-
cellular dynamics, which remain qualitatively similar amongst the three glioma cell lines 
investigated here in silico. Rather, we find that cells with higher EGFR density show an early 
increase in the phenotypic switching activity between proliferative and migratory traits, linked 
to a higher level of initial auto-stimulation by the PLCγ-mediated TGFα-EGFR autocrine 
network. This indicates a more active protein level interaction in these chemotactically acting 
tumor systems and supports the role of post-translational regulation for the implemented 
EGFR pathway. Implications of these results for experimental cancer research are discussed.  
 
 
1. INTRODUCTION 
 
The epidermal growth factor receptor (EGFR) has been widely implicated in tumorigenesis in 
the brain (Diedrich et al., 1995). Early clinical studies have found that up to four in ten 
specimen of highly-malignant brain tumors or gliomas overexpress EGFR due to gene 
amplification (Libermann et al., 1985a, 1985b). Furthermore, this EGFR amplification 
correlates with rapid glioma growth and invasion (Lund-Johansen et al., 1990; Lund-Johansen 
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et al., 1992; Schlegel et al., 1994; Westermark et al., 1982) thus rendering the EGFR signaling 
pathway of importance for a better understanding of tumor growth dynamics.  
 
Detailed steady state modeling of EGFR dynamics has already investigated the binding, 
internalization and degradation of ligands (Wiley and Cunningham, 1981). Later work has 
addressed aspects like the role of endocytosis (Starbuck and Lauffenburger, 1992), differential 
feedback in response to different ligands (Brightman and Fell, 2000) and the robustness of an 
extended EGFR network to initial values (Schoeberl et al., 2002). Furthermore, spatial 2D 
models of EGFR signaling have also examined pattern generation with multiple (Shvartsman 
et al., 2002) and single cells (Maly et al., 2004). Finally, a model of TGFα EGFR signaling 
(Owen and Sherratt, 1998) has already shown to be capable of pattern formation in a multi-
cellular environment (Owen et al., 2000). Taken together, computational modeling and 
quantitative experimentation of the EGFR pathway have therefore addressed reaction kinetics 
as well as the effect on cell-behavior like proliferation and migration (reviewed in 
Lauffenburger and Linderman, 1996).  
 
Giese et al. (1996) first proposed that a dichotomy exists between these phenotypes of 
migration and proliferation in growing tumors, i.e. that cells either replicate or migrate, yet do 
not display both traits at the same time. Wells (1999) proposed that the EGFR pathway and its 
downstream elements like Phospholipase Cγ (PLCγ) could provide the molecular mechanism 
for such dichotomy. In fact, experimental evidence has accumulated for a prominent role of 
Phospholipase Cγ (PLCγ) in mediating migratory and proliferative responses on EGFR 
stimulation (Chen et al., 1994, 1996). Recent experimental data suggested a correlation 
between rate of PLCγ concentration changes and the migratory and proliferative phenotypes 
(Dittmar et al., 2002). We have employed this mechanism in our previously developed agent-
based ‘microscopic-macroscopic’ brain tumor model (Mansury et al., 2002; Mansury and 
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Deisboeck, 2003, 2004a, 2004b). Further incorporating an EGFR molecular gene-protein 
interaction network and spatial distribution module, we were able to demonstrate that one can 
indeed simulate the dichotomy between cell migration and proliferation based on an 
intracellular EGFR-dependent gene-protein decision network (Athale et al., in press).  
 
In order to better understand the interaction between molecular dynamics at the protein level 
and multicellular tumor growth patterns, specifically in the context of EGFR signaling, we 
again employ this multiscale cancer model. Here, we, however, vary the expression level of 
EGFR protein and examine its impact on multicellular tumor dynamics, cellular phenotype 
and single cell molecular profiles. We find the overall spatio-temporal expansion to be faster 
in tumors with higher EGFR densities. The very same cells show an earlier onset of 
phenotypic switching activity, presumably related to a faster change in average PLCγ 
concentration and to an earlier increase in extracellular TGFα concentration. The following 
section describes the specific algorithm employed here. 
 
2. MODEL 
 
Our specific agent-based model is described elsewhere in detail (Athale et al., in press). In 
brief, the algorithm spans several orders of magnitude from the sub-cellular and cell-cell 
interaction level up to the macroscopic tumor scale. In the following, we will briefly 
summarize the setup. 
 
2.1. Sub-cellular dynamics  
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Here, the smallest unit of the simulated tumor is the molecular entity, which forms a gene-
protein interaction network governed by mass balance equations. The molecules are related to 
the EGFR pathway and reactions are first and second order differential equations in which 
threshold values determine the behavior of the cell. The mass-balance equation takes the 
following generic form: 
 
ii
i XX
dt
dX ⋅−⋅= βα ,      (1) 
 
where Xi is the mass of the i-th molecule, α is the rate of synthesis or increase and β is its rate 
of degradation or removal of a molecular species. A schematic of the gene-protein interaction 
network is displayed in Fig. 1a while Table 1 lists the network’s individual molecules.  
 
Table 1 
 
The interaction network is implemented in the regions of the nucleus, cytoplasm and cell 
membrane (Fig. 1b). A molecule in one or more of these regions is also distributed in four 
spatially oriented sub-compartments, i.e. North, South, East and West. The molecular flux 
between these sub-compartments (Fig. 1c) is governed by the following equation: 
 
[ ] jioutjijiinji XkXXkdtdX ,1,1,, 2 ⋅⋅−+⋅= +− ,    (2) 
 
where Xi,j  is the concentration of the molecule Xi in a given compartment j, while Xi,j-1 refers 
to the neighboring compartment before Xi,j  and Xi,j+1 to the compartment after Xi,j. Here, j (1 
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to 4) is the compartment number and kin and kout are the flux rate constants into and out of the 
compartment, respectively. 
 
Figure 1a 
Figure 1b 
Figure 1c 
 
2.2. Cellular decision making 
 
In our cellular decision model a tumor cell can ‘choose’ either to migrate or to proliferate, yet 
does not perform both phenotypic activities at the same time, hence implementing Giese et al. 
(1996) aforementioned dichotomy concept. Furthermore, Dittmar et al. (2002) could show in 
breast cancer cells that PLCγ is activated transiently and to a greater extent during migration 
and more gradually in the proliferative ‘mode’. We therefore adopt a simple threshold, σPLC, 
to decide whether the cell should undergo migration or not. Thus the potential to migrate is 
assessed by a cell evaluating the following function: 
 
[ ]
n
n dt
PLCdPLCM 

= )()( γγ ,      (3) 
 
where d(PLCγ)/dt is the change in concentration of PLCγ over time (t) and n is the cell 
number. If Mm>σPLC the cell becomes eligible to migrate, otherwise it could proliferate or 
become quiescent (i.e., it neither proliferates nor migrates, yet remains viable). If the cell 
decides to migrate, the direction of migration is expressed in terms of a local valuation 
function for each neighboring lattice point j in the von Neumann neighborhood as follows: 
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[ ] ( ) [ ] PLCj
mj
jjjj PLCPLCnnPLCL Ψ⋅−⋅−= ≤ )][(maxarg)(1),( γγγ ,  (4) 
 
where Lj is the value of a grid point in the neighborhood of the cell; the neighboring grid 
locations and compartments are numbered as j (1 to 4). In a given sub-cellular compartment j, 
(PLCγ) is the concentration of activated PLCγ, n is the number of cells at that location in the 
neighborhood and m is the total number of compartments (here: m=4). ]1,0[∈ΨPLC  denotes 
the so-called search-precision parameter, representing the biological equivalent of a receptor-
driven, non-erroneous evaluation of the permissibility of the microenvironment as discussed 
in detail in our previous work (Athale et al., in press; Mansury and Deisboeck, 2003). For 
instance, when the search precision parameter PLCΨ  = 0, the cell performs a pure random 
walk, and when PLCΨ  = 1 the cells never commits ‘mistakes’ and always migrate fully biased 
to the most permissive location with the highest level of PLCγ (based on Eq. 4). 
 
If the change in concentration of active PLCγ is below the migration-threshold, σPLC, yet 
above a set noise threshold, σn, then the cell evaluates the proliferative potential Pprolif ≥0. 
This potential is calculated using Eq. 5, 
 
[ ] EGFRprolif LRLRP σ−= )()( ,     (5) 
 
where (LR) is the concentration of ligand bound phosphorylated TGFα-EGFR complex in a 
cell. This function is derived from experimental observations citing cell proliferation in 
relation to an EGF-receptor threshold (Knauer et al., 1984) and an experimentally validated 
model, which relates receptor occupancy to percent maximal proliferation (Lauffenburger and 
Linderman, 1996). Again, if neither the conditions for migration nor proliferation are met, the 
cell turns quiescent. Cell death is currently not considered in our model here.  
Athale C.A., Deisboeck T.S.: Receptor Density in a Multiscale Tumor Model 
 8
2.3. Cell-cell communication 
 
Every such cell has a molecular interaction network that includes the protein transforming 
growth factor alpha, TGFα, which is produced by the cell based on a constant rate of secretion 
(see also Fig. 1a). Previous work has pointed to the fact that TGFα capture is rapid, meaning 
that most of the hormone is captured by the very same cell producing it (Shvartsman et al., 
2001). Therefore, in our simulation it is deposited onto the neighboring lattice grid without 
any explicit diffusion modeled. It may thus act not only autocrine but also in a paracrine 
manner, i.e. affecting neighboring cells, as has been demonstrated for breast cancer (de Jong 
et al., 1998). 
 
2.4. Environmental conditions 
 
Finally, the virtual environment is made up of a finite number S of regular points that are part 
of a torroidal grid lattice in two-dimensions, where 2RS =  and R is the length of a square 
section of the grid (R=200). Each point of the lattice Sx,y (where x and y indicate the integer 
location in Euclidean terms) can be either empty or carry a single cell. The simulation 
recreates a scenario where a mass of tumor cells ( 1000 ==tn ) is initialized in the geometric 
center of the grid, and a cross-sectioned blood vessel located in the North-East (NE) Quadrant 
acts as a replenished source of nutrients with glucose diffusing down the concentration 
gradient, and the edge of the rectangular lattice acts as a perfect sink. The simulation is 
terminated when the first tumor cell reaches the edge of this nutrient source. This time point is 
used as a measure to determine the spatio-temporal expansion velocity of the tumor system. 
 
3. RESULTS 
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3.1. Simulation methods 
 
The model was implemented in Java (Sun Microsystems, Inc., USA) using the agent-based 
modeling toolkit Repast (version 2.0; http://repast.sourceforge.net). The mass-balance 
equations representing the gene-protein network were solved using Euler finite time stepping. 
Simulation runs were performed on a workstation with dual Intel Xeon 2.3GHz processors, 
connected via gigabit Ethernet to the central file storage system and running Linux. Three 
runs with different parameter values took 1 hour, 25 min and 26 seconds to complete. 
 
3.2. Multicellular patterns 
 
As a measure of the overall tumor growth rate, we examined the effect of varying the cell 
surface-bound EGFR protein concentration per cell over three orders of magnitude (i.e., ~104–
106 EGFR per cell) on the spatio-temporal expansion velocity. As noted before, the simulated 
tumor growth is halted when the first cell enters the edge of the nutrient source located in the 
NE Quadrant. The results show that tumor growth accelerates with increasing receptor density 
(Fig. 2) and attains a maximum velocity in the range of 106 receptors per cell. The number of 
receptors reported in a previous study on in vitro invasion of glioma cell lines (Lund-Johansen 
et al., 1990) is superimposed (on the X-axis) for comparison.  
 
Figure 2 
 
 
3.3. Sub-cellular localization dynamics of PLCγ 
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To further investigate a potentially molecular cause of these distinct multicellular patterns 
which emerge both in time (Fig. 2) and space (Fig. 3a) we first monitored the polarization of 
the molecular concentration profiles of PLCγ in the most aggressive migratory cell, i.e. the 1st 
cell to reach the edge of the cross sectional blood vessel, for each of the three cell lines (Fig. 
3b). Evidently, the time evolution results (scaled to start with the time point of origin of that 
cell) show a qualitatively very similar PLCγ polarization pattern, turning from homogeneous 
to a heterogeneous one, where the highest localization is in the cytosolic compartment facing 
the nutrient source in the NE quadrant.   
 
Figure 3a 
Figure 3b 
 
3.4. Phenotypic switching  
 
Interestingly, when investigating the cell line-specific ability to switch between phenotypic 
traits (migratory, proliferative or quiescent), we found that increasing EGF-receptor density 
leads to an earlier onset of switching events in the tumor system from the quiescent (Q) to 
migratory (M) and/or proliferative (P) cell phenotypes (Fig. 4a). Moreover, the cell line with 
the highest EGFR density (per cell, iii) switches earlier between proliferative and migratory 
traits (Fig. 4b), and vice versa (Fig. 4c).   
 
Figure 4a 
Figure 4b 
Figure 4c 
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Thus, the larger the number of EGF receptors per cell, the earlier is the onset of phenotypic 
switching events mediated through the EGFR gene-protein interaction network.  
 
In an attempt to delve into the possible molecular basis of such switching behavior and its 
earlier onset, we plotted the average values of the major components of our network over time 
(Fig. 5).The plots show that the cell-average of PLCγ concentration changes most gradually in 
the cell type with the lowest EGFR density (i) and faster in the cell types with increased 
EGFR (ii) and (iii) (Fig. 5a). Interestingly, although TGFα does not directly influence the 
phenotype in our model, our result shows that early increases in extracellular TGFα 
concentration (0.4-0.6 nM) correlate with the more invasive, high-EGFR density cell line 
(Fig. 5b).  
Figure 5a 
Figure 5b 
 
4. DISCUSSION and CONCLUSIONS 
 
Results from numerous experimental and clinical studies support the notion that the epidermal 
growth factor receptor is critically involved in various aspects of brain tumorigenesis. 
Employing our previously developed multiscale agent-based brain tumor model, we therefore 
investigated in here how variations on the receptor level affect both the sub-cellular as well as 
the multi-cellular tumor dynamics. Specifically, as a first step we varied the number of EGF-
receptors within our EGFR-gene-protein module and simulated its impact across the scales of 
interest. 
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In accordance with experimental findings reported by Berens et al. (1996), our results show 
that the rate of spatio-temporal tumor expansion accelerates with increasing EGFR density per 
cell (Lund-Johansen et al., 1990), but reaches a plateau in the high receptor densities beyond 
which no further acceleration can be achieved. This increase and saturation of the expansion 
rate also supports results from our previous works (Mansury and Deisboeck, 2003; Mansury 
and Deisboeck, 2004a; 2004b) in which we could for instance show that up to a certain point 
a more precise spatial search process increases the rate of expansion of the entire tumor. 
While that work already implied receptor-mediated chemotaxis, the EGFR receptor, however, 
had not been explicitly modeled. Most importantly, our findings show now that early onset of 
phenotypic alternations is an intrinsic feature of such aggressive tumors. Interestingly, this 
refers to changes in both directions, i.e., from the proliferative to the migratory trait and vice 
versa. This means that both cellular phenotypes are necessary for overall rapid tumor 
expansion, which in turn hints on a critical role of the network’s switching activity. 
Investigating this then further, we found that while cells with more EGFR molecules seem to 
take slightly longer to polarize, the resulting spatial patterns of PLCγ distribution are, 
however, qualitatively similar. Instead it appears that this earlier onset in ‘switching’ behavior 
is at least to some extent related to both, a faster change in average PLCγ concentration per 
cell and an early increase in TGFα protein secreted by these cells. Since, at the same time the 
gene expression level of TGFα and EGFR in the three cell lines considered does not differ, 
our results indicate that the EGFR dependent increased expansion rate depends largely on 
post-translational events. Interestingly, this switching between phenotypes could help explain 
the findings of immunostaining studies of glioma clinical samples, where EGFR and TGFα 
protein expression were found to correlate with increasing malignancy. While this did not 
correlate well with the Ki-67 mitotic index, it was however suggested to correlate with the 
early onset of autocrine signaling (von Bossanyi et al., 1998). From a therapeutic perspective, 
it is then noteworthy that EGFR kinase inhibitors were able to block this very same auto-
Athale C.A., Deisboeck T.S.: Receptor Density in a Multiscale Tumor Model 
 13
stimulatory TGFα-EGFR loop in a subcutaneous glioma model in mice (El-Obeid et al., 
2002). Furthermore, a PLCγ specific inhibitor that blocks binding and activation of growth 
factor receptors indeed reduced the infiltration rate of human glioblastoma spheroids 
(Khoshyomn et al., 1999). 
 
As such, our finding may well be of interest for experimental and clinical cancer research 
alike as it indicates that changes in the EGFR pathway cannot be detected by monitoring gene 
expression data alone. Rather, proteomics data from tissue specimen should be included in the 
evaluation if predictive assessments of tumor growth dynamics are intended. We note that we 
did not yet examine in detail the impact of a concomitant EGFR gene-copy number increase 
on our molecular network, since data from human glioma samples are ambiguous with 
regards to the precise quantitative link between EGFR protein overexpression and gene-
amplification (Fleming et al., 1992). While it is therefore a reasonable first step to vary the 
receptor protein amount per cell separately, we plan in future studies to investigate in more 
detail the initially stated close relationship between gene amplification and malignancy. Our 
preliminary findings using experimentally measured values of EGFR gene copy number 
increases in gliomas of up to 100-fold (Okada et al., 2003) indicate that increasing EGFR 
copies in silico do not linearly correlate with expansion velocity changes, thus seemingly 
further supporting the role of the protein in our admittedly limited network. While future work 
will also include implementing a more complex three-dimensional environmental setting, it is 
thus evident that one must strive to eventually anchor the EGFR pathway within a more 
extended sub-cellular interaction network, including for instance other tyrosine-kinase 
receptor cascades, apoptosis pathways and cell division pathways.  
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Yet, regardless of these current limitations, the presented results yield several experimentally 
testable hypotheses and thus support further refinement for and use of such multiscale models 
in interdisciplinary cancer research.   
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TABLE AND FIGURE CAPTIONS 
 
Table 1. Depicted are the variables of the EGFR gene-protein interaction network 
model here, and the molecular species they represent. Where no references were available in 
the literature reasonable estimates were used instead. 
 
Figure 1. (a) The molecular decision network consists of positive and negative 
feedbacks (arrows with + and –) and mass action kinetics (black arrows) between genes and 
proteins. The cellular decisions are indicated with grey arrows. (b) Each cell in the model 
consists of a central nuclear space surrounded by cytoplasm and a membrane compartment. 
These 2D compartments are further divided into four sub-compartments in the cardinal 
directions, each connected to two others. The gray sub-compartmental region (c) shows intra-
compartmental flux determined by a rate of inflow (kin) and outflow (kout) as represented by 
solid arrows, while the stippled arrows indicate the exchange of mass between different 
compartments as a result of gene-protein interactions.  
 
Figure 2. Plotted here is the time it takes for the first tumor cell to reach the edge of the 
glucose source (Y-axis) versus the number of EGFR receptors per cell (X-axis). The error 
bars result from 23 runs with different random number seeds. The points (gray circles) on the 
X-axes indicate increasing EGF-receptor counts of (i) 2.9x104, (ii) 1.5x105 and (iii) 1.59x106 
per cell, as reported by (Lund-Johansen et al., 1990) for three different human glioma cell 
lines (i) D-263 MG, (ii) D-247 MG and (iii) D-37 MG, respectively. 
 
Figure 3.  Shown is the 2D cross-section of (a) a tumor spheroid system at the time point 
when the first cell invades the edge of the nutrient source (located in the NE quadrant), for the 
three different cell lines (see Fig. 2). (b) Depicted is the localization of PLCγ in this first cell 
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at five (rescaled) consecutive time points. The color bar indicates the PLCγ concentration in 
[nM]. 
 
Figure 4. (a) The number of events in which quiescent tumor cells (Q) switch their 
phenotype to a migratory or proliferative trait (M/P) (Y-axis) is plotted for the three cell lines 
(i, ii and iii) over time (X-axis). (b) Depicted are the phenotypic changes from proliferative 
(P) to migratory (M) and, in (c), from the migratory to the proliferative trait. The data is 
superimposed from 30 runs with different random number seeds. 
 
Figure 5. Here the average concentration of (a) cellular PLCγ, and (b) neighboring extra-
cellular TGFα (in [nM]) of all viable tumor cells is plotted on the Y-axis over time (X-axis) 
for the three cell lines (i), (ii) and (iii). The plots from multiple runs (n=30) with different 
random number seeds are superimposed on one another. 
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FIGURES and TABLES 
 
Table 1. 
 
Symbol Variable Initial 
Values 
[nM] 
Reference 
X1 TGFα extracellular protein 1 (Dowd et al., 
1999) 
X2 EGFR cell surface receptor 25 (Maly et al., 
2004) 
X3 Dimeric TGFα-EGFR cell surface 
complex 
0 - 
X4 Phosphorylated active dimeric TGFα-
EGFR cell surface complex 
0 - 
X5 Cytoplasmic inactive dimeric TGFα-
EGFR complex 
0 - 
X6 Cytoplasmic EGFR protein 0 - 
X7 Cytoplasmic TGFα protein 1 Estimate 
X8 EGFR RNA 1 (Kues et al., 
2001) 
X9 TGFα RNA 0 (Kues et al., 
2001) 
X10 PLCγ Ca-bound 1 (Piccolo et al., 
2002) 
X11 PLCγ active, phosphorylated, Ca-
bound 
1 (Kim et al., 
1990) 
X12 Glucose cytoplasmic 1 (Pfeuffer et al., 
2000) 
X13 Glucose extracellular 0 - 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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